ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,275.38
0.54%
Dow Jones
38,686.32
1.51%
Gold vs US Dollar
2,327.355
0.00%
Brent Oil
81.295
0.00%
Bitcoin
67,584.92
0.15%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. NeuroMetrix Inc (NURO)

  7. NeuroMetrix Inc (NURO) News

NeuroMetrix (NURO)

NeuroMetrix Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NURO
DateTimeSourceHeadlineSymbolCompany
31/05/202418:15Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:NURONeuroMetrix Inc
24/05/202422:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NURONeuroMetrix Inc
24/05/202422:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NURONeuroMetrix Inc
24/05/202422:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NURONeuroMetrix Inc
15/05/202421:00GlobeNewswire Inc.NeuroMetrix Reports Q1 2024 Business HighlightsNASDAQ:NURONeuroMetrix Inc
15/05/202417:33Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:NURONeuroMetrix Inc
15/05/202416:19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NURONeuroMetrix Inc
07/05/202421:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NURONeuroMetrix Inc
19/04/202413:00GlobeNewswire Inc.NeuroMetrix Announces Steps Taken to Enhance Shareholder ValueNASDAQ:NURONeuroMetrix Inc
14/03/202413:00GlobeNewswire Inc.NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral NeuropathyNASDAQ:NURONeuroMetrix Inc
13/03/202413:00GlobeNewswire Inc.NeuroMetrix announces that over 2000 patients with fibromyalgia have been prescribed Quell® FibromyalgiaNASDAQ:NURONeuroMetrix Inc
06/03/202422:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NURONeuroMetrix Inc
06/03/202422:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NURONeuroMetrix Inc
06/03/202422:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NURONeuroMetrix Inc
06/03/202422:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NURONeuroMetrix Inc
04/03/202421:12Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:NURONeuroMetrix Inc
01/03/202422:07Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:NURONeuroMetrix Inc
27/02/202421:45Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:NURONeuroMetrix Inc
27/02/202421:00Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:NURONeuroMetrix Inc
26/02/202422:41Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:NURONeuroMetrix Inc
22/02/202412:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NURONeuroMetrix Inc
22/02/202412:00GlobeNewswire Inc.NeuroMetrix Reports Q4 and Full Year 2023 Business HighlightsNASDAQ:NURONeuroMetrix Inc
20/02/202419:49Edgar (US Regulatory)Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:NURONeuroMetrix Inc
15/02/202414:00GlobeNewswire Inc.NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2023 Business Highlights Conference CallNASDAQ:NURONeuroMetrix Inc
13/02/202414:00GlobeNewswire Inc.NeuroMetrix Announces Review of Strategic Options to Promote Growth and Maximize Shareholder ValueNASDAQ:NURONeuroMetrix Inc
12/12/202314:00GlobeNewswire Inc.NeuroMetrix Reports Encouraging Results from Pilot Clinical Trial of Quell® in Post-Acute COVID-19 Syndrome (Long COVID)NASDAQ:NURONeuroMetrix Inc
05/12/202314:00GlobeNewswire Inc.NeuroMetrix Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Showing that Quell® Improves Painful Symptoms of Chemotherapy Induced Peripheral Neuropathy (CIPN)NASDAQ:NURONeuroMetrix Inc
20/11/202314:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NURONeuroMetrix Inc
20/11/202314:00GlobeNewswire Inc.NeuroMetrix Announces One-for-Eight Reverse Stock SplitNASDAQ:NURONeuroMetrix Inc
26/10/202321:20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NURONeuroMetrix Inc
 Showing the most relevant articles for your search:NASDAQ:NURO

Your Recent History

AMEX
IOX
Iomed
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved